Web Stats Provided By Google Analytics

Monday, January 27, 2014

Insurers revolt against $84,000 hepatitis drug

As Gilead Sciences Inc. touted its $1,000-a-pill hepatitis C cure to investors in a hotel ballroom in San Francisco, a group of about 20 protesters milled outside.

http://ift.tt/1mOvJgc
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)